Trevi Therapeutics, Inc.

NASDAQ:TRVI

3.04 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Operating Activities:
Net Income -12.352-10.902-7.821-7.698-7.145-6.401-5.505-8.266-8.052-7.329-8.52-7.255-9.794-8.371-9.523-7.378-7.384-8.473-6.537-7.365-7.346-4.802-5.982-5.654-4.858-4.051-0.002
Depreciation & Amortization 0.0380.0350.0350.0350.0340.0190.0150.0090.0080.0110.0120.0130.0120.0130.0130.0130.0110.010.0090.0110.010.0090.0130.0040.0040.0020
Deferred Income Tax 000.023-0.472-0.63100000-0.0530.005-0.040.0060.009000-1.57600000000
Stock Based Compensation 1.1270.7230.5340.530.6050.5780.5010.5690.520.7370.540.540.7450.7180.510.5880.5890.730.3730.3710.2370.1460.1850.1210.1020.0880
Change In Working Capital 2.727-0.0620.7360.207-2.977-1.813-0.882-0.8141.141-0.6761.635-0.6950.658-0.089-0.092-0.258-1.6523.06-0.047-0.7511.8750.4990.9020.787-1.365-0.892-0
Accounts Receivables 00000000000000-0.206000.433-0.3740-00.034-0-0-0-0-0
Change In Inventory 00000000000000-41.35800-44.581-55.13500-10.44900000
Change In Accounts Payables -0.6180.2940.627-0.17-0.592-0.9140.536-1.4682.051-1.110.615-1.2552.686-1.2150.758-1.9020.9670.5941.109-2.0461.899-0.185-0.058-0.0560.0710.1090
Other Working Capital 3.345-0.3560.1090.377-2.3850.914-1.4180.654-0.910.4341.020.56-2.0281.12640.7141.644-2.61946.61454.3531.295-0.02411.0990.960.843-1.436-1.001-0
Other Non Cash Items 1.5980.2380.1340.1190.239-0.58-0.46-0.0740.2070.1650.1570.1510.5210.1450.1590.0680.0010.0011.576-0.0020.1630.0520.1480.7490.5070.899-0
Operating Cash Flow -8.683-10.467-6.359-7.279-9.875-8.197-6.331-8.576-6.176-7.092-6.229-7.241-7.898-7.578-8.924-6.967-8.436-4.673-6.202-7.734-5.061-4.096-4.734-3.993-5.61-3.954-0.003
Investing Activities:
Investments In Property Plant And Equipment -0.0280-0.022-0.018-0.04-0.057-0.116-0.043000000-0.005-0.015-0.01200.00900-0.009-0.0920.001-0.01-0.057-0
Acquisitions Net 000.67100-0.6711.201-1.9580000000000000000000
Purchases Of Investments -9.958-30.264-0.95100-8.981-65.19-6.808-54.217000000000000000000
Sales Maturities Of Investments 12.75422.17313.8181819.67918172.001-0.072000000000000000000
Other Investing Activites 0.0030.3810.0130.0180.020.671-1.2011.9580.07200000-0.032000000-0.00900000
Investing Cash Flow 2.768-8.09112.84517.98219.6398.962-48.306-4.85-54.21700000-0.005-0.015-0.01200.00900-0.009-0.0920.001-0.01-0.057-0
Financing Activities:
Debt Repayment -0.031-0.032-0-0-0.008-0.002-1.75-1.75-1.75-0.5830-0.0680000000000-0.002-0-0.003-0.002-0.002
Common Stock Issued 0.2480.004-1.7321.5410.0280.0472.451.18451.826-0.04213.6780.5332.7944.1780.6932.442000.038009.96300000
Common Stock Repurchased 0000000000000000000.138-0.138000-0.026000
Dividends Paid 000000000000000000-2.23900-1.55300000
Other Financing Activities 4.850.004-00.002000.0025.8685.902-0.0420.063-0.399-0.041-0.031-0.05613.653-0.01202.063-00.0640.01-0.0020.01-0.00100
Financing Cash Flow 5.067-0.028-00.002-0.008-0.0020.65255.30255.978-0.62513.7410.1342.7534.1470.63716.095-0.01200-00.0640.01-0.0020.01-0.003-0.002-0.002
Other Information:
Effect Of Forex Changes On Cash 0013.869-12.002-1.8670000000000000000000000
Net Change In Cash -0.848-18.5866.43212.2132.101-0.938-53.98541.876-4.415-7.7177.512-7.107-5.145-3.431-8.2929.113-8.46-4.673-6.202-7.87258.4415.744-6.3326.476-8.901-6.061-0.005
Cash At End Of Period 12.96313.81132.39725.96513.75211.65112.58966.57424.69829.11336.8329.31836.42541.5745.00153.29344.1852.6457.31363.51571.38712.9467.20213.5347.05815.9590.022